The Cochrane Library App presents the latest up-to-date evidence from the Cochrane Library in a convenient, easy to navigate format which provides you with relevant, accessible research, when you need it, from the world’s leading experts in evidence-informed health care.
All content in the app is free and new issues will download regularly.
Our monthly issues feature a hand-picked selection of Cochrane Systematic Reviews, specifically chosen by the Editor-in-chief. Abridged Cochrane Reviews provide the best possible tablet and phone reading experience and they are downloadable for reading offline. The Bookmark feature allows you to create your own special collection of Cochrane Reviews across issues. Additionally, the title page for every review includes a link to the full version of the review available on the Cochrane Library.
Hello, and welcome to the March 2020 issue of the Cochrane Library app.
The Cochrane Reviews in this month's edition cover a diverse set of topics ranging from advance care planning for adults with heart failure, omega-3 fatty acids to prevent cardiovascular disease, cognitive training for dementia in Parkinson’s disease, and home fortification of foods with micronutrient powders. Topics also include obesity prevention within childcare services, acupuncture to manage pain during labour, biologics for chronic rhinosinusitis, and prevention of suicide by jumping.
Our main review this month is 'Pharmacological interventions for heart failure in people with chronic kidney disease '. Approximately half of people with heart failure have chronic kidney disease (CKD), in which pharmacological interventions have the potential to reduce death or hospitalisations. However, these interventions are of uncertain benefit and may increase the risk of harm in those with CKD, such as hypotension and electrolyte abnormalities. Authors from the Cochrane Kidney and Transplant Group looked at the benefits and harms of pharmacological interventions for heart failure (i.e., antihypertensive agents, inotropes, and agents that may improve the heart performance indirectly) in people with heart failure and CKD.
The abridged version of this review is available in this issue. Visit www.cochranelibrary.com to read the full version.
Our monthly issues produced exclusively for the app feature a hand‐picked selection of Cochrane Systematic Reviews, specifically abridged to provide the best possible mobile reading experience. You can create your own special themed collection of Cochrane Reviews across issues in the app on topics such as occupational health by using the app’s Bookmark feature.
The title page for every review included in this and previous issues includes a link to the full version of the review available on the Cochrane Library at www.cochranelibrary.com.